Proteus One is a compact proton therapy that offers optimized Pencil Beam Scanning and image guidance. So far, IBA has signed 13 contracts to provide the system to healthcare systems throughout the world.
“Any hospital considering proton therapy can now afford it through the Proteus One’s lower capital and operating costs without making any clinical compromise,” Beth Klein, president of IBA Proton Therapy North America, said. “Ultimately, this will make proton therapy more accessible to the radiation therapy patients in the United States who can benefit from it.”
IBA expects to launch the proton therapy system in less than a year.
More articles on medical devices:
FDA approves expanded indications of heart valve
Medtronic issues warning for heart valve delivery system following 19 deaths
FDA notifies 14 international medical device companies about regulatory violations
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
